JY
VNRX icon

Jeff Yass’s VolitionRx Ltd VNRX Stock Holding History

Jeff Yass’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-955
Closed -$36.5K – 13233
2023
Q1 		$36.5K Sell
955
-375
-28% -$15.7K ﹤0.01% 11833
2022
Q4 		$64.6K Sell
1,330
-310
-19% -$12K ﹤0.01% 11252
2022
Q3 		$45K Sell
1,640
-465
-22% -$17.6K ﹤0.01% 12273
2022
Q2 		$86K Buy
2,105
+430
+26% +$21.7K ﹤0.01% 11612
2022
Q1 		$101K Sell
1,675
-290
-15% -$16.4K ﹤0.01% 11910
2021
Q4 		$123K Sell
1,965
-55
-3% -$3.75K ﹤0.01% 11987
2021
Q3 		$125K Buy
2,020
+450
+29% +$28.5K ﹤0.01% 11922
2021
Q2 		$103K Buy
+1,570
New +$106K ﹤0.01% 12085

Other funds holding VNRX

LIM
Lagoda Investment Management New York $182M AUM 58.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LM
Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return

Jeff Yass's VNRX Position: Q1 2026 in Review

Jeff Yass sold out of VolitionRx Ltd (VNRX) in Q1 2026, closing a stake of 2,842 shares — an estimated $14.5K sold.

Jeff Yass first reported a position in VNRX in Q4 2018 and held it in 17 quarters. The position peaked at $249K in Q1 2021. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2026.

  • Jeff Yass reported no remaining VolitionRx Ltd position as of Q1 2026 after selling out during the quarter.
  • Jeff Yass sold 2,842 VolitionRx Ltd shares in Q1 2026, an estimated $14.5K.
  • Jeff Yass first reported a position in VolitionRx Ltd in Q4 2018 and held it in 17 quarters.
  • Jeff Yass's VolitionRx Ltd position peaked at $249K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.